2 Minute Medicine Rewind January 6, 2020
Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: ...
Tag: Pembrolizumab
2 Minute Medicine Rewind October 28, 2019
PD-1 blockade in advanced adrenocortical carcinoma 1. Pembrolizumab may provide clinically meaningful anti-tumor activity in the setting of adrenocortical carcinoma, ...
Quick Take: Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study
Immunotherapies such as anti-PD-1 (anti-programmed cell death 1) and anti-PD-L1 (anti-programmed cell death ligand 1) are effective in treating numerous ...
2 Minute Medicine Rewind June 10, 2018
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, ...
Quick Take: Pembrolizumab Versus Chemotherapy for Previously Untreated, PD-L1-Expressing, Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (KEYNOTE-042)
Pembrolizumab is a monoclonal antibody against programmed cell death protein 1 (PD-1). Previous studies have shown that pembrolizumab is effective ...
2 Minute Medicine Rewind March 20, 2017
Association between maternal body mass index in early pregnancy and incidence of cerebral palsy Cerebral palsy is the most ...
PD-1 blocker pembrolizumab may be a promising therapy for advanced Merkel-cell carcinoma
1. Using immune checkpoint blockade, this phase 2 study showed favourable complete and partial response rates, and increased progression free ...
2 Minute Medicine Rewind April 25, 2016
Patient Outcomes When Housestaff Exceed Eight Hours per Week Over a decade ago, the Accreditation Council for Graduate Medical Education ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
